Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Open-Label, Active Controlled, Single-Center, Phase 1 Study to Determine the Anhidrotic Area and Safety of MEDITOXIN in Healthy Male Volunteers

NCT03647982 is registered in ClinicalTrials.gov with Medy-Tox as lead sponsor.

NCT NCT03647982
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03647982 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Open-Label, Active Controlled, Single-Center, Phase 1 Study to Determine the Anhidrotic Area and Safety of MEDITOXIN in Healthy Male Volunteers
Lead sponsor
Medy-Tox
Phase
Phase 1
Overall status
Completed
Start date
March 20, 2018
Completion date
November 20, 2018
Enrollment
13 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

anhidrotic area, hyperhidrosis